StockData
Kyntra Bio, Inc. logo

Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$2.04−1.16 (-36.25%)

Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –

Kyntra Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Kyntra Bio's price to book ratio was 84.3× on Jan 31, 2023, against 4.3× a year earlier. Over the last 5 years it ranged from 3.2× to 84.3×, with a median of 7.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 202384.3×+27.1
2022Dec 30, 202257.2×+53.2
2021Dec 31, 20214.0×−3.5
2020Dec 31, 20207.5×+1.2
2019Dec 31, 20196.3×−2.0
2018Dec 31, 20188.3×+1.5
2017Dec 29, 20176.8×−0.8
2016Dec 30, 20167.6×−1.0
2015Dec 31, 20158.6×–

More Kyntra Bio figures

See a number that looks wrong?